Wolters Kluwer acquires Health Language

Editorial Staff | | Health Exec | Digital Transformation

Wolters Kluwer Health, a developer of information and business intelligence systems, has entered into an agreement to acquire Health Language, a medical terminology management (MTM) company.

Health Language's medical content terminology databases and software technologies enable hospitals, EHR system developers and payers to manage, update and map disparate medical vocabularies and administrative codes used in U.S. and international settings. The company's databases and software products include more than 180 standard terminologies and proprietary content sets. The company also provides clinical content and professional services for interoperability, web-based terminology mapping, Meaningful Use compliance and ICD-10 conversion, a system of coding created by the World Health Organization that is in various phases of implementation, according to Wolters Kluwer. 

Health Language is headquartered in Denver and has approximately 85 employees.

The transaction is subject to customary closing conditions, including the receipt of required regulatory approvals. Terms of the acquisition were not disclosed.

Editorial Staff

Related Content

2024 in AI weirdness: ‘Insane’ ChatGPT and mutant rat genitals were only the beginning
10 signs AI is ‘eating the world (of venture capital)’
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.